Cited by 40Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

APOE ɛ4 Gene Dose and Sex Effects on Alzheimer’s Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment

Open access
Hobel, Zachary, for the Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing, Isenberg, A. Lisette, Raghupathy, Dhvani, Mack, Wendy, Pa, Judy·2019·Journal of Alzheimer's Disease

Abstract

BACKGROUND: APOEɛ4 and sex have been linked to increased risk for conversion to Alzheimer's disease (AD). However, the relationship between APOEɛ4 gene dose, sex, and AD biomarkers remains understudied. OBJECTIVE: To investigate the effect of APOEɛ4 dose on AD biomarkers in a sample of older adults with mild cognitive impairment (MCI), and to examine whether APOEɛ4 dose modifies AD risk differently in MCI women and men. METHODS: We examined cross-sectional AD biomarkers for participants with MCI (n = 930, 55-96 years old) from three large aging cohorts. Region of interest MRI volumes, global cognition, and episodic memory were analyzed by number of APOEɛ4 alleles and stratified by sex. RESULTS: Across all participants, number of APOEɛ4 alleles was associated with smaller hippocampal and amygdala volumes and poorer cognition. When stratified by sex, women showed an APOEɛ4 dose effect for bilateral hippocampal and left amygdala volumes and cognition. In contrast, men showed an APOEɛ4 dose effect for hippocampal volumes with a trend in amygdala, but cognition did not differ between men with 1 and 2 APOEɛ4 alleles. Women with 2 APOEɛ4 alleles had poorer memory between 65-69 and poorer global cognition between 70-74 compared to men with 2 APOEɛ4 alleles. CONCLUSION: APOEɛ4 confers a dose effect on AD biomarkers in patients with MCI, and the number of APOEɛ4 alleles has a greater detrimental impact in women than men, which may be specific to a critical time window.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-180859

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies reporting sex-specific associations of APOE4 with WM integrity and stronger APOE-related differences in brain metabolism and cortical atrophy for women than men provide grounds for deeper exploration of sex differences.

    “studies reporting sex-specific associations of APOE4 with WM integrity [19] and stronger APOE-related differences in brain metabolism and cortical atrophy for women than men [20, 21] provide grounds for deeper exploration of sex differences in underlying cytoarchitecture.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 40

Authors
Hobel, Z., ageing, F. T. A. D. N. I. A. T. A. I. B. A. L. F. S. O., Isenberg, A. L., Raghupathy, D., Mack, W., & Pa, J.
Affiliations
University of Southern California (US)
Corresponding author
Pa, Judy
Venue
Journal of Alzheimer's Disease
Published
2019-09-17
Volume
71
Issue
2
Pages
647-658
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2968503742
Cited by
40
References
51
Citations by year
2026: 1 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 7 · 2020: 4
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Foundation for the National Institutes of Health (P50 AG016574, AG016574, P30 AG010133, P50 AG005138, U01 AG016976)
  • Alzheimer's Association (P30 AG013854, U01 AG016976, P50 AG025688, P50 AG008702, P30 AG010133, P50 AG005146)
  • Pfizer
  • University of Southern California
  • Meso Scale Diagnostics
  • Novartis Pharmaceuticals Corporation
  • Northern California Institute for Research and Education
  • Commonwealth Scientific and Industrial Research Organisation
  • Servier
  • H. Lundbeck A/S
  • National Institutes of Health (5u01ag024904-10, AG016574, AG016976, AG005138, AG008051, AG019610, AG005134, AG013854, AG025688, AG013846, AG047266, AG008702)
  • Canadian Institutes of Health Research (P50 AG016574)
  • National Institute on Aging (U01-AG-024904, AG 005138, AG010133, AG 016976, P30AG010129, P30AG010133, AG008051, AG005134, P30AG028383, P30AG012300, AG 025688, AG016574, P50AG005133, U01AG016976, P50AG005131, AG-013854, P50AG005138, P50AG016570, AG019610, P30AG010124, AG047266, P50AG016573, P50AG047366, P30AG008017, P30AG010161, P30AG008051, P50AG008702, P50AG033514, P30AG035982, AG013846, P50AG005681, P50AG005142, P50AG047270, P30AG019610, P50AG005146, RF1AG054617, P30AG013846, P50AG005136, P50AG005134, P30AG013854, P50AG025688, P50AG047266, R01AG046928, P50AG023501, P50AG016574)
  • National Institute of Biomedical Imaging and Bioengineering (U54EB020406, P41EB015922)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
APOE ε4, gene dosage
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cross-Sectional Studies, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Sex Characteristics, Cohort Studies, Gene Dosage, Apolipoprotein E4, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review